The association of GLP-1 with atherosclerosis in animals has been well established, proving anti-inflammatory effects of GLP-1 on atherosclerotic plaques by modulating inflammatory pathways and activity of macrophages
There are some people that should not take tirzepatide
Before initiating treatment with Tirzepatide, a glucagon-like peptide-1 (GLP-1) receptor agonist , healthcare providers should check patients for a history of hypoglycemia (low blood sugar), especially if they are on concurrent treatments known to lower glucose levels like sulfonylureas or insulin
Regular assessment should include glycemic control (A1C every three months initially), weight trends, gastrointestinal tolerability, and screening for potential complications
If you need help converting your new dose to syringe units at your specific vial concentration, use the Tirzepatide Dosage Calculator
In the heart of Lincoln, Nebraska, access semaglutide both as a convenient injection and an oral pill